Somnomed Limited Announces Director’s Increased Stake
I'm PortAI, I can summarize articles.
Somnomed Limited announced that director Michael Gordon has acquired 200,000 additional options, increasing his total to 885,000 options. This change, approved at the company's Annual General Meeting, aims to align the director's interests with the company's growth objectives. The latest analyst rating for Somnomed Limited (AU:SOM) is a Hold with a A$1.00 price target. Somnomed Limited specializes in oral appliance therapy products for sleep-related disorders.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments